03839nam 2200637Ia 450 991014060280332120230725023239.00-470-88896-21-282-55051-997866125505150-470-60378-X0-470-60377-1(CKB)2670000000014443(EBL)510175(OCoLC)609861425(SSID)ssj0000364534(PQKBManifestationID)11262326(PQKBTitleCode)TC0000364534(PQKBWorkID)10399025(PQKB)10513053(MiAaPQ)EBC510175(Au-PeEL)EBL510175(CaPaEBR)ebr10375598(CaONFJC)MIL255051(EXLCZ)99267000000001444320091029d2010 uy 0engur|n|---|||||txtccrPortfolio, program, and project management in the pharmaceutical and biotechnology industries[electronic resource] /edited by Pete HarpumHoboken, N.J. John Wiley & Sonsc20101 online resource (352 p.)Description based upon print version of record.0-470-04966-9 Includes bibliographical references and index.Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries; Contents; Preface; Acknowledgments; About the Authors; Part One The Life Science Industry Context for Portfolio, Program, and Project Management; 1. A Review of Project Management in Life Science Industry Sectors; 2. The Impact of Organizational Size on Drug Project Management; 3. Drug Development in Biotechnology and How We Can Do It Better; Part Two The Portfolio, Program, and Project Management Approaches and Processes4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market; 6. Program Management in Drug Development; 7. Project Control; 8. Managing Uncertainty in Drug Projects; 9. Managing Drug Safety Risk; 10. Developing Program Strategy; 11. Developing Products with "Added Value"; Part Three Integrating the Processes; 12. Integrated Business Processes to Support Cross-Functional Drug Development13. Integrated Drug Development: From Cradle to Grave and from Lab to Market14. The Development of P(3)M Capability in Drug Development Organizations; 15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations; Bibliography; IndexThis book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.Pharmaceutical industryManagementBiotechnology industriesManagementProject managementPharmaceutical industryManagement.Biotechnology industriesManagement.Project management.615.1068/4Harpum Pete862905MiAaPQMiAaPQMiAaPQBOOK9910140602803321Portfolio, program, and project management in the pharmaceutical and biotechnology industries1926375UNINA